Damage to the gastrointestinal tract during graft versus host disease (GVHD) from the conditioning regimen in conjunction with alloreactive donor T cells plays a pivotal role in the pathogenesis of this disease. In this study, we have identified secretion of interleukin 23 (IL-23) by donor antigen-presenting cells (APCs) as a critical event in the induction of GVHD of the colon linking conditioning regimeninduced mucosal injury and lipopolysaccharide (LPS) translocation to subsequent proinflammatory cytokine production and GVHD-associated pathological damage. In the absence of donor APC-derived IL-23 secretion, there is a selective and profound reduction in pathological damage as well as a marked reduction in LPS and proinflammatory cytokine production in the colon microenvironment. The downstream proinflammatory effects of IL-23 are dependent upon donor-derived secretion of IFN-γ, but are independent of donor IL-17 production. These findings define a novel organ-specific role for IL-23 in the pathophysiology of GVHD and demonstrate that IL-23 can direct tissue-specific pathology within the context of a systemic inflammatory disorder. Furthermore, these studies also identify IL-23 as a potential therapeutic target for the prevention of this life-threatening disorder.
INTRODUCTION
Host antigen presenting cells (APCs) play a pivotal role in the initiation of GVHD through their presentation of host peptides to alloreactive donor T cells 1, 2 . This results in the subsequent activation and expansion of donor T cells leading to cytokine production and acquisition of effector function which together mediate target organ damage [2] [3] [4] [5] . Dendritic cells (DCs), in particular, are one, if not, the most critical APC population in GVHD and have been shown to be sufficient for the induction of the disease 6 .
Eventually, host APCs are eliminated and replaced by donor APCs which become the predominant APC population 7, 8 and present host antigens to donor T cells via the indirect pathway of allorecognition 9, 10 .
Recent studies have provided evidence that donor APCs may play a role in GVHD pathophysiology through their ability to propagate and maximize the severity of GVHD 11, 12 . The mechanism(s) by which these cells contribute to GVHD pathogenesis, however, remains poorly defined.
While DC interactions with T cells are critical for initiation of GVHD, DCs also elaborate cytokines that are able to shape and amplify the immune response 13 . IL-12 is a type I cytokine comprised of two subunits (p35 and p40) that is secreted by DCs and has an important role in the development of T H 1 immune responses [14] [15] [16] . More recently, another heterodimeric type I cytokine was discovered which possesses structural similarities to IL-12 and is also secreted by DCs, as well as other APCs such as macrophages. This cytokine, termed IL-23, shares the p40 subunit with IL-12 but has a novel p19 component which together binds to receptors present on memory/activated T cells, DCs and macrophages [17] [18] [19] . Secretion of IL-23 by APC populations has been shown to have proinflammatory effects that are mediated by both T cells and cells of the innate immune system [20] [21] [22] . IL-23 is able to induce proliferation and IFN-γ secretion in memory, but not naïve, CD4 + T cells 17, 23 due to the expression of the unique IL-23 receptor subunit on the former but not the latter cells 24 .
IL-23 also appears to be
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From necessary for a fully functional T H 17 response which constitutes a CD4 + T cell population that has a critical role in a number of inflammatory syndromes, including collagen-induced arthritis, 25 experimental allergic encephalomyelitis (EAE), 26 and the autoimmunity that occurs as a consequence of GVHD 27 . A proinflammatory role for IL-23 independent of T cells is supported by studies using immunodeficient mice that lack T cells which have shown that IL-23 plays a critical role in the induction of intestinal inflammation that occurs as a consequence of either bacterial infection or agonistic anti-CD40 antibody administration 20, 21 . This has been postulated to be due to direct effects of IL-23 on cells of the innate immune system such as monocytes and macrophages that result in their secretion of proinflammatory cytokines (IL-1, IL-6 and TNF-α) 28, 29 . Given the emerging role of donor APCs in GVHD biology coupled with the proinflammatory profile that is conferred by secretion of IL-23, the purpose of the current study was to examine the role of donor APC-derived IL-23 in the pathophysiology of GVHD.
MATERIAL AND METHODS
Mice. C57BL/6 (B6) Histological Analysis. Representative samples of liver, colon, and lung were obtained from transplanted recipients and fixed in 10% neutral-buffered formalin. Samples were then embedded in paraffin, cut into five micron thick sections and stained with hematoxylin and eosin. A semiquantitative scoring system was employed to account for histological changes in the colon and liver as previously described. 27 Histological changes compatible with GVHD of the lung were interstitial/alveolar inflammation along with periluminal bronchial and vascular infiltrates. Interstital/alveolar inflammation was graded as none, mild (<25%), moderate (25-50%), and severe (>50%). The extent of periluminal disease was determined using the scoring system of Cooke et al 31 and then dividing the cumulative score by four to obtain an average periluminal index. Interstitial/alveolar inflammation and periluminal disease were then combined to achieve a total GVHD lung score. Images were visualized with a Nikon Eclipse E400 microscope and a Nikon Plan APO 10x/0.45 lens (Nikon, Tokyo, Japan). Image acquisition was performed with a Zeiss Axiom camera and Axiovision 3.0.6 SPZ software (Zeiss, Berlin, Germany).
Cytokine Analysis. Serum was collected from mice by retroorbital bleeds and analyzed on a Bioplex System (BioRad Laboratories, Hercules, CA) according to the manufacturer's instructions. To assess cytokine concentration in colonic supernatant, small pieces of colon ( 5 mm of mid-colon) were isolated and weighed under aseptic conditions. 21 Colon explants were cultured overnight in complete RPMI 1640
(Gibco-BRL) at 37°C. After centrifugation to pellet debris, culture supernatants were analyzed for IL23p19 using a specific sandwich ELISA (eBiosciences) or all pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-17, G-CSF, IL-12, and IFN-γ) using the multi-plex cytokine Bio-Rad assay system. Cytokine levels were normalized to the weight of the colon explants. All samples were run in duplicate.
Serum Lipopolysaccharide (LPS) determination. For determination of endotoxin concentration, the
Limulus Amebocyte Lysate (LAL) assay (Cambrex Bio Science, Walkersville, MD) was performed according to the manufacturer's protocol. The absorbance of the assay plate was read at 405 nm (Bio-Tek Instruments, Inc., Winooski, VT). Samples and standards were run in duplicate and the lower limit of detection was 0.10 U/ml. LPS levels were normalized to the weight of the colon explants.
Cell Isolation. Splenic CD4 + and CD8 + T cells were isolated by positive selection using the MACS magnetic bead cell separation system (Miltenyi Biotech, Auburn, CA). To isolate lamina propria mononuclear cells (LPMCs), pooled colons were incubated in Hank's Balanced Salt Solution (HBSS) buffer (Gibco-BRL) supplemented with 5% fetal bovine serum (FBS), EDTA (0.05 mM), Hepes buffer (0.6 mM), penicillin (100 units/ml)/streptomycin (100 µg/ml, Gibco-BRL), and 15 µg/ml dithiothreitol (Invitrogen, Carlsbad, CA) at 37°C for 30 min and subsequently digested in a solution of collagenase D (Roche Diagnostics, 0.2 mg/ml) in RPMI medium for 1h at 37°C. To isolate lamina propria lymphocytes (LPLs), the resulting cell suspension was layered on a 44%/67% Percoll gradient (Sigma, St. Louis, MO).
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Intracellular Cytokine Staining. Lymphocytes isolated from spleen, liver and colon were stimulated with phorbol 12-myristate 13-acetate (PMA) (Sigma) and ionomycin (Calbiochem, La Jolla, CA) as previously described. 27 Cells were surface stained with PE Cy5.5 anti-CD4 (Caltag) and then intracellularly stained with PE-labeled antibody to IL-17 or FITC-labeled antibody to IFN-γ (BD Pharmingen). accomplished using the mathematical model described by Pfaffl 33 .
Real
Statistics. Group comparisons of T and B cell populations, cytokine levels, LPS levels, pathology scores, mean weights and gene expression data were performed using the Mann Whitney U test. Survival curves were constructed using the Kaplan-Meier product limit estimator and compared using the log rank rest. A p value ≤ 0.05 was deemed to be significant in all experiments. Figure 1A ). In order to understand the mechanism by which mice transplanted with IL-23 -/-marrow grafts were protected from GVHD lethality, we repeated these studies with a reduced donor T cell dose so that mice in all groups would survive and be able to be examined for immunological reconstitution and pathological analysis. In 
. Individual GVHD target organ scores, however, revealed that the protective effect derived from the transplantation of IL-23 -/-grafts was manifested only in the colon as there was no difference in pathology scores in either the lung or the liver. Similar findings were observed when these studies were repeated using a B6→FVB murine GVHD model ( Figure 3B ). In these experiments, the composite pathology score was also significantly reduced in animals that received IL-23 -/-marrow grafts (10.9 ± 0.9 versus 7.8 ± 0.8, p=0.01), however, the colon was the only target organ with a significant reduction in pathological 
IL-23 and IL-23 receptor gene expression is increased in colon-derived APCs and CD4 + T cells during GVHD.
To further investigate the preferential protection observed in the colon, we examined IL-23 mRNA levels in the spleen, liver and colon to determine whether there was differential gene expression in these organs during GVHD. We observed that, in comparison to normal nontransplanted Balb/c mice, there was a selective increase in IL-23 (3-fold) mRNA levels in the colon of GVHD animals, as no differences between normal and GVHD mice were seen in the spleen or liver ( Figure 5A ). Notably, Analysis of IL-23R mRNA levels was then conducted to determine which cells in the colon were responsive to the actions of IL-23. We observed that gene expression for the IL-23R was increased in both CD11c + CD11b + and CD11b + CD11c − cells in the colon as well as the spleen of GVHD animals when compared to normal spleen cells ( Figure 5D ). The most striking finding, however, was that there was a dramatic increase (~1000-fold) in IL-23R expression in purified colon-derived CD4 + T cells whereas CD4 + T cells isolated from the spleen or liver of these same mice had negligible expression. LPS is able to trigger cytokine release from mononuclear cells through engagement of TLR4 and the resulting "cytokine storm" contributes to local damage as well as systemic toxicity. We observed that animals transplanted with IL-23 -/-marrow grafts had a significant reduction in serum LPS levels as early as day 7 when compared to GVHD controls ( Figure 7A ). This disparity was even more pronounced when similarly transplanted mice were examined 3-4 weeks post-BMT, indicative of an increase in systemic LPS levels with ongoing GVHD ( Figure 7B ). A kinetic examination of colonic explant supernatants in GVHD control mice revealed a progressive increase in LPS levels over the first four weeks ( Figure 7C ).
In contrast, transplantation with IL-23 -/-marrow grafts resulted in a 70-80% reduction in LPS levels beginning 2 weeks post transplantation. Notably, the sharp rise in LPS levels in GVHD control animals occurred approximately one week earlier than the increase in IL-23 levels ( Figure 4A ), supporting the premise that LPS translocation was a proximate trigger for subsequent secretion of IL-23 by donor APCs.
LPS signaling has been shown to occur through the binding to a LPS receptor complex composed of TLR4, MD2 and CD14 on the surface of macrophages and dendritic cells [37] [38] [39] . We therefore examined TLR4 mRNA levels in the spleen, liver and colon to determine whether there was differential gene expression in these organs during GVHD. We observed that there was a selective increase in TLR4 (14-fold) mRNA levels in the colon of GVHD animals ( Figure 7D ). Moreover, mice that were protected from colonic GVHD after transplantation with IL-23 -/-marrow grafts had a significant reduction in TLR4 (3- For
DISCUSSION
In this study, we demonstrate that IL-23 has a unique and selective role in the induction of colonic inflammation during acute GVHD and serves as a critical mediator linking conditioning regimen-induced mucosal injury and LPS translocation to subsequent proinflammatory cytokine production and GVHDassociated pathological damage. The major finding was that GVHD target organ protection in the absence of donor APC-derived IL-23 was restricted to the colon (Figure 3 (Figure 7 ). An important aspect of our studies was that we also observed a modest degree of systemic protection in mice transplanted with IL-23 -/-grafts. These animals had significantly less weight loss and overall improved thymic and splenic reconstitution ( Figure 1 ). Moreover, we observed a reduction in some (i.e. TNF-α and IL-17), but not all, inflammatory cytokines ( Figure 2 ) as well a marked reduction in serum endotoxin levels in these mice ( Figure 7 ). Our data appear to have clinical relevance based on a recent report 40 For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Our studies did, however, identify a crucial role for IFN-γ in IL-23-mediated pathological damage during GVHD. In the absence of donor-derived IFN-γ secretion, there was a significant reduction in pathology and proinflammatory cytokine production in the colon (Figure 6 ). LPS and IL-23 levels were also substantially reduced consistent with a feedback loop mechanism whereby reduced pathological damage leads to decreased translocation of LPS across mucosal surfaces and reduced IL-23 secretion. A role for IFN-γ in GVHD-induced colonic damage has precedence from studies which have shown that IFN-γ can prime macrophages which license them to release significant quantities of proinflammatory cytokines after exposure to LPS 44 . IFN-γ can also mediate direct effects on colonic enterocytes inducing crypt hyperplasia and villous atrophy 45 and recent data suggest that these actions may play a dominant role in GVHD of the colon 46 . Another important result from these studies is the confirmation that mucosal pathology mediated by IL-23 can occur in a T H 17 independent manner. While two prior studies 47,48 have also made this observation, the mechanism by which this occurred was not elucidated. Our studies now The results of this study may have clinical implications beyond the direct application to GVHD.
Separation of graft versus leukemia (GVL) and GVH reactivity has been a longstanding but elusive goal in clinical allogeneic BMT. The inability to dissociate these two responses stems in part from the fact that alloreactive donor T cells are equally capable of trafficking to sites of disease as well as target organs such as the colon, liver and skin. The ability to selectively inhibit the ability of donor T cells to mediate pathological damage in a specific target organ without interfering with the ability of these same cells to traffic to sites of underlying disease is a potential strategy that might allow for the separation of GVL and GVH effects. Although further experimentation is clearly required to validate this premise, our data demonstrating the unique role that IL-23 has in the pathophysiology of GVHD of the colon raises the possibility that in vivo blockade of IL-23 might be a clinically applicable approach that would permit the dissociation of GVHD-induced gut toxicity from an otherwise systemically directed GVL response.
Finally, our finding that a single cytokine can have profound effects in mediating pathological damage in a specific GVHD target organ raises the possibility that other, as of yet unidentified, cytokines may be responsible for directing pathology in selected tissue sites, not only in GVHD, but more generally in other systemic inflammatory disorders. For 
